This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Conduit Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company whose business model inherently relies on animal testing. The company develops novel therapeutics, a process that requires preclinical testing on animals to assess safety and efficacy before human clinical trials can begin. This commercial exploitation of animals for research and development is a foundational component of the pharmaceutical industry and central to Conduit's operations.
The provided evidence does not detail specific incidents of animal testing by Conduit Pharmaceuticals. However, the company's sector and developmental stage indicate its involvement in standard industry practices where animal models are used to evaluate potential drug candidates. The exclusion under this category reflects the firm's participation in the commercial system of animal exploitation for biomedical research.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.